MedTrace Logo

Genetic Susceptibility to Periprosthetic Joint Infections

NCT05159739 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-03-19

No results posted yet for this study

Summary

The investigators primary objective is to identify genetic factors that may increase the risk of patients developing a periprosthetic joint infections (PJI) following total joint arthroplasty (TJA). The investigators hope that by identifying genetic predispositions we will be able to provide patient specific care pathways to prevent or minimize the risk for PJI.

Conditions

  • Total Joint Arthroplasty
  • Periprosthetic Joint Infections

Interventions

GENETIC

Blood Draw or Saliva/Cheek Cell Sample:

Collected samples will immediately undergo genetic analysis to determine the presence or absence of potential candidate genes responsible for the increased incidence of PJI.

Sponsors & Collaborators

Principal Investigators

  • Jeremy Gililland, M.D. · University of Utah

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-07
Primary Completion
2028-03-31
Completion
2028-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05159739 on ClinicalTrials.gov